Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Other Operating Expenses: 2015-2021

Historic Other Operating Expenses for Assembly Biosciences (ASMB) over the last 3 years, with Dec 2021 value amounting to $41.6 million.

  • Assembly Biosciences' Other Operating Expenses was N/A to $41.6 million in Q4 2021 from the same period last year, while for Dec 2021 it was $41.6 million, marking a year-over-year change of. This contributed to the annual value of $41.6 million for FY2021, which is N/A change from last year.
  • According to the latest figures from Q4 2021, Assembly Biosciences' Other Operating Expenses is $41.6 million, which was up 4,163,700.00% from $1,000 recorded in Q4 2019.
  • Over the past 5 years, Assembly Biosciences' Other Operating Expenses peaked at $41.6 million during Q4 2021, and registered a low of -$127,000 during Q2 2018.
  • For the 2-year period, Assembly Biosciences' Other Operating Expenses averaged around $10.4 million, with its median value being $2,500 (2019).
  • As far as peak fluctuations go, Assembly Biosciences' Other Operating Expenses slumped by 39,713.53% in 2018, and later spiked by 104.35% in 2019.
  • Quarterly analysis of 4 years shows Assembly Biosciences' Other Operating Expenses stood at -$447 in 2017, then plummeted by 39,713.53% to -$82,000 in 2018, then soared by 103.15% to $1,000 in 2019, then reached $41.6 million in 2021.
  • Its Other Operating Expenses stands at $41.6 million for Q4 2021, versus $1,000 for Q4 2019 and $4,000 for Q2 2019.